Century Therapeutics (IPSC) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $45.6 million.
- Century Therapeutics' Accumulated Depreciation & Amortization rose 3930.67% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 3930.67%. This contributed to the annual value of $36.1 million for FY2024, which is 5788.6% up from last year.
- According to the latest figures from Q3 2025, Century Therapeutics' Accumulated Depreciation & Amortization is $45.6 million, which was up 3930.67% from $42.5 million recorded in Q2 2025.
- Over the past 5 years, Century Therapeutics' Accumulated Depreciation & Amortization peaked at $45.6 million during Q3 2025, and registered a low of $6.5 million during Q1 2022.
- Over the past 4 years, Century Therapeutics' median Accumulated Depreciation & Amortization value was $22.8 million (recorded in 2023), while the average stood at $24.7 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 15532.6% in 2023, then surged by 3930.67% in 2025.
- Over the past 4 years, Century Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $13.7 million in 2022, then surged by 67.25% to $22.8 million in 2023, then soared by 57.89% to $36.1 million in 2024, then increased by 26.49% to $45.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $45.6 million for Q3 2025, versus $42.5 million for Q2 2025 and $39.1 million for Q1 2025.